Salmi M - Search Results

1

Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis.

Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, Johansson M, Brennan P, Key T, Lewis SJ, Martin RM, Murphy N, Platz EA, Travis R, Yarmolinsky J, Zuber V, Martin P, Katsoulis M, Freisling H, Nøst TH, Schulze MB, Dossus L, Hung RJ, Amos CI, Ahola-Olli A, Palaniswamy S, Männikkö M, Auvinen J, Herzig KH, Keinänen-Kiukaanniemi S, Lehtimäki T, Salomaa V, Raitakari O, Salmi M, Jalkanen S; PRACTICAL consortium; Jarvelin MR, Dehghan A, Tsilidis KK. Bouras E, et al. Among authors: salmi m. BMC Med. 2022 Jan 11;20(1):3. doi: 10.1186/s12916-021-02193-0. BMC Med. 2022. PMID: 35012533 Free PMC article.

2

Regulation of L-selectin expression on cultured bone marrow leukocytes and their precursors.

Salmi M, Jalkanen S. Salmi M, et al. Eur J Immunol. 1992 Mar;22(3):835-43. doi: 10.1002/eji.1830220331. Eur J Immunol. 1992. PMID: 1372261

3

Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus.

Hänninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Hänninen A, et al. Among authors: salmi m. J Clin Invest. 1992 Nov;90(5):1901-10. doi: 10.1172/JCI116067. J Clin Invest. 1992. PMID: 1385478 Free PMC article.

4

A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans.

Salmi M, Jalkanen S. Salmi M, et al. Science. 1992 Sep 4;257(5075):1407-9. doi: 10.1126/science.1529341. Science. 1992. PMID: 1529341

5

Regulation of lymphocyte traffic to mucosa-associated lymphatic tissues.

Salmi M, Jalkanen S. Salmi M, et al. Gastroenterol Clin North Am. 1991 Sep;20(3):495-510. Gastroenterol Clin North Am. 1991. PMID: 1917024 Review.

6

Serum CD44 in malignant lymphoma: an association with treatment response.

Ristamäki R, Joensuu H, Salmi M, Jalkanen S. Ristamäki R, et al. Among authors: salmi m. Blood. 1994 Jul 1;84(1):238-43. Blood. 1994. PMID: 7517210 Free article.

7

Dual binding capacity of mucosal immunoblasts to mucosal and synovial endothelium in humans: dissection of the molecular mechanisms.

Salmi M, Andrew DP, Butcher EC, Jalkanen S. Salmi M, et al. J Exp Med. 1995 Jan 1;181(1):137-49. doi: 10.1084/jem.181.1.137. J Exp Med. 1995. PMID: 7528765 Free PMC article.

8

Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.

Salmi M, Jalkanen S. Salmi M, et al. Eur J Immunol. 1995 Oct;25(10):2803-12. doi: 10.1002/eji.1830251014. Eur J Immunol. 1995. PMID: 7589075

Vascular adhesion protein-1 (VAP-1) is a novel endothelial cell molecule which mediates lymphocyte binding to the vascular lining (Salmi, M., and Jalkanen, S., Science 1992. 257:1407). In this study, we analyzed endothelial cell type-specific differences of VAP-1. . …

Vascular adhesion protein-1 (VAP-1) is a novel endothelial cell molecule which mediates lymphocyte binding to the vascular lining (Salmi …

9

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73.

Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S. Airas L, et al. Among authors: salmi m. J Exp Med. 1995 Nov 1;182(5):1603-8. doi: 10.1084/jem.182.5.1603. J Exp Med. 1995. PMID: 7595232 Free PMC article.

10

Tumor endothelium selectively supports binding of IL-2-propagated tumor-infiltrating lymphocytes.

Salmi M, Grenman R, Grenman S, Nordman E, Jalkanen S. Salmi M, et al. J Immunol. 1995 Jun 1;154(11):6002-12. J Immunol. 1995. PMID: 7751643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page